Cary Street Partners Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$2.43M Buy
26,970
+182
+0.7% +$15.3K 0.32% 80
2024
Q2
$2.11M Buy
26,788
+4,519
+20% +$370K 0.31% 82
2024
Q1
$1.94M Sell
22,269
-133
-0.6% -$11.4K 0.3% 85
2023
Q4
$1.85M Sell
22,402
-95
-0.4% -$7.24K 0.32% 87
2023
Q3
$1.76M Sell
22,497
-211
-0.9% -$17.7K 0.33% 80
2023
Q2
$2M Sell
22,708
-24
-0.1% -$2.07K 0.37% 71
2023
Q1
$1.83M Buy
22,732
+270
+1% +$22K 0.35% 77
2022
Q4
$1.75M Sell
22,462
-1,649
-7% -$134K 0.35% 73
2022
Q3
$1.95M Buy
24,111
+3,262
+16% +$293K 0.47% 56
2022
Q2
$1.87M Sell
20,849
-2,581
-11% -$262K 0.44% 62
2022
Q1
$2.6M Buy
23,430
+7,340
+46% +$775K 0.52% 50
2021
Q4
$1.66M Buy
16,090
+5,183
+48% +$600K 0.36% 75
2021
Q3
$1.37M Sell
10,907
-71
-0.6% -$9.19K 0.48% 70
2021
Q2
$1.36M Sell
10,978
-42,045
-79% -$5.28M 0.33% 82
2021
Q1
$1.63M Buy
53,023
+207
+0.4% +$24.3K 0.4% 74
2020
Q4
$1.63M Buy
+52,816
New +$5.81M 0.48% 68

Other funds holding MDT

Cary Street Partners Asset Management's MDT Position: Q3 2024 in Review

Cary Street Partners Asset Management increased its Medtronic (MDT) stake by 0.68% in Q3 2024, buying an estimated $15.3K and bringing the position to 26,970 shares worth $2.43M. The position accounts for 0.32% of the portfolio, ranked #80.

Cary Street Partners Asset Management first reported a position in MDT in Q4 2020 and has held it in 16 quarters since. The position peaked at $2.6M in Q1 2022. 2,064 funds tracked by Wall St. Rank hold MDT as of Q3 2024.

  • Cary Street Partners Asset Management held 26,970 shares of Medtronic worth $2.43M as of Q3 2024.
  • Cary Street Partners Asset Management bought 182 Medtronic shares in Q3 2024, an estimated $15.3K.
  • Medtronic made up 0.32% of Cary Street Partners Asset Management's portfolio in Q3 2024, its #80 holding.
  • Cary Street Partners Asset Management first reported a position in Medtronic in Q4 2020 and has held it in 16 quarters since.
  • Cary Street Partners Asset Management's Medtronic position peaked at $2.6M in Q1 2022.
  • 2,064 funds tracked by Wall St. Rank held Medtronic as of Q3 2024.

Based on Cary Street Partners Asset Management's 13F filing for Q3 2024, filed 30 Oct 2024.